Can biosimilars help achieve the goals of US health care reform?
Ralph Boccia,1 Ira Jacobs,2 Robert Popovian,3 Gilberto de Lima Lopes Jr4 1Center for Cancers and Blood Disorders, Bethesda, MD, 2Global Medical Affairs, Pfizer Inc., New York, NY, 3US Government Relations, Pfizer Inc., Washington, DC, 4Sylvester Comprehensive Cancer Center, University of Miami, Miam...
Main Authors: | Boccia R, Jacobs I, Popovian R, de Lima Lopes Jr G |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-06-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/can-biosimilars-help-achieve-the-goals-of-us-health-care-reform-peer-reviewed-article-CMAR |
Similar Items
-
Lessons from Health Reform
by: Trish Riley
Published: (2013-12-01) -
Biosimilars Adoption: Recognizing and Removing the RoadBlocks
by: Niazi SK
Published: (2023-04-01) -
Drug tendering: drug supply and shortage implications for the uptake of biosimilars
by: Dranitsaris G, et al.
Published: (2017-09-01) -
Provider and Consumer Engagement in Care Coordination Models: Evidence from the U.S.
by: Leslie Greenwald
Published: (2015-05-01) -
Provider and Consumer Engagement in Care Coordination Models: Evidence from the U.S.
by: Leslie Greenwald
Published: (2015-05-01)